Skip to content

PolitiKit

Lobbying by MS Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

MS Canada

Meetings this Parliament
0
With MPs
0
Since Nov 2021
0
Active registrations
1

Registrations in effect

Consultant In effect since May 20, 2026 Receives government funding

Consultant Mary Anne Carter of Earnscliffe Strategy Group

Consultant lobbyists

  • Mary Anne Carter
  • Mary Anne Carter
  • Mary Anne Carter

Institutions they may lobby: Accessibility Standards Canada, Atlantic Canada Opportunities Agency (ACOA), Canada Employment Insurance Commission, Canada Post Corporation (CPC), Canada Revenue Agency (CRA), Canadian Heritage (PCH), Canadian Human Rights Commission (CHRC), Canadian Institutes of Health Research (CIHR), Canadian Transportation Agency (CTA), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Office of the Commissioner of Lobbying (OCL), Office of the Federal Housing Advocate, Office of the Information Commissioner of Canada (OIC), Office of the Privacy Commissioner of Canada (OPC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Rural Economic Development (Minister’s Office), Senate of Canada, Service Canada (ServCan), Social Sciences and Humanities Research Council (SSHRC), Statistics Canada (StatCan), Transport Canada (TC), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC), Women and Gender Equality (WAGE)

What they're lobbying on (17)
  • Canadian Institutes of Health Research (CIHR) as it relates to federal funding & long term investment in health research.
  • Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved Mutiple Sclerosis (MS) disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.
  • We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
  • Safe Long-Term Care Act with respect to persons affected by MS.
  • National Housing Strategy with respect for persons with MS and other chronic conditions and disabilities.
  • Measures and funding for the charitable sector generally.
  • Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers.
  • Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
  • Establishment of national strategy for neurological conditions, with respect to persons with MS and other neurological conditions.
  • Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities.
  • Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities.
  • Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities.
  • Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities.
  • Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including MS care.
  • Canada Health Act and regulations, as it relates to long-term and home care.
  • Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty.
  • Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities.

Registration 929175-377696-6. Look it up in the official Registry

Reported meetings

No meetings reported since November 2021.

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.